Apotheek Baeskens SRL

Apotheek Baeskens reported total assets of 413,989 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).

Company number (CBE) 0477.868.124 · VAT BE0477868124
9340 Lede
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 01 Jul 2002 (≈ 24 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheek Baeskens shows with a free account.

See the score
Profile
SRL since 2002
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result10,947 €
Equity372,183 €
Cash94,603 €
EBITDA27,903 €
Total assets413,989 €
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +10 % Total assets -5 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheek Baeskens's annual accounts

20252024202320222021
Net result10,947 €
Equity372,183 €
Cash94,603 €
EBITDA27,903 €
Total assets413,989 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 22 Jun 2026
  • Year ended 31 Dec 2024filed on 19 May 2025
  • Year ended 31 Dec 2023filed on 05 Jun 2024
  • Year ended 31 Dec 2022filed on 31 Jul 2023
  • Year ended 31 Dec 2021filed on 26 Jul 2022

Apotheek Baeskens's financial analysis

Management and control of Apotheek Baeskens

2 active director(s) in the register.

Apotheek Baeskens's shareholders and holdings →

Apotheek Baeskens's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0477.868.124
VAT number
BE0477868124
Peppol
Registered · 0208:0477868124 · as of 10 Nov 2026
Legal form
SRL
Incorporated
01 Jul 2002
Registered office
9340 Lede
Latest accounts
2025 · filed on 22 Jun 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheek Baeskens (SRL) has been based in Lede since 2002, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 10,947 € and equity of 372,183 €; its revenue is not published. Its solvency stands at 89.9%, above the median of its sector (44.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Apotheek Baeskens

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheek Baeskens

What is the revenue of Apotheek Baeskens?

Apotheek Baeskens files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Apotheek Baeskens?

In Belgium, the VAT number is the company number prefixed with BE: BE0477868124 for Apotheek Baeskens, if the company is VAT-registered. Its company number (CBE) is 0477.868.124.

Where is the registered office of Apotheek Baeskens?

According to the CBE register, the registered office of Apotheek Baeskens is in 9340 Lede.

What is the equity of Apotheek Baeskens?

At the close of the 2025 financial year, the equity of Apotheek Baeskens amounts to 372,183 €, a solvency of 89.9% of total assets.

Who manages Apotheek Baeskens?

The register lists 2 active mandates at Apotheek Baeskens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheek Baeskens

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 10 Jul 2026

No credit card, no commitment.

What each plan unlocks →